Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition.

Siddiqui I, Erreni M, Kamal MA, Porta C, Marchesi F, Pesce S, Pasqualini F, Schiarea S, Chiabrando C, Mantovani A, Allavena P.

Oncoimmunology. 2017 Nov 1;7(2):e1388485. doi: 10.1080/2162402X.2017.1388485. eCollection 2018.

2.

Effects of dipeptidyl peptidase-4 (DPP-4) inhibition on angiogenesis and hypoxic injury in type 2 diabetes.

Fiordaliso F, Maggioni S, Balconi G, Schiarea S, Corbelli A, De Luigi A, Figliuzzi M, Antoniou X, Chiabrando C, Masson S, Cervo L, Latini R.

Life Sci. 2016 Jun 1;154:87-95. doi: 10.1016/j.lfs.2016.03.052. Epub 2016 Mar 31.

PMID:
27040669
3.

In-depth glycoproteomic characterization of γ-conglutin by high-resolution accurate mass spectrometry.

Schiarea S, Arnoldi L, Fanelli R, De Combarieu E, Chiabrando C.

PLoS One. 2013 Sep 12;8(9):e73906. doi: 10.1371/journal.pone.0073906. eCollection 2013.

4.

Neuroprotective effects of toll-like receptor 4 antagonism in spinal cord cultures and in a mouse model of motor neuron degeneration.

De Paola M, Mariani A, Bigini P, Peviani M, Ferrara G, Molteni M, Gemma S, Veglianese P, Castellaneta V, Boldrin V, Rossetti C, Chiabrando C, Forloni G, Mennini T, Fanelli R.

Mol Med. 2012 Sep 7;18:971-81. doi: 10.2119/molmed.2012.00020.

5.

Secretome analysis of multiple pancreatic cancer cell lines reveals perturbations of key functional networks.

Schiarea S, Solinas G, Allavena P, Scigliuolo GM, Bagnati R, Fanelli R, Chiabrando C.

J Proteome Res. 2010 Sep 3;9(9):4376-92. doi: 10.1021/pr1001109.

PMID:
20687567
6.

Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility.

Solinas G, Schiarea S, Liguori M, Fabbri M, Pesce S, Zammataro L, Pasqualini F, Nebuloni M, Chiabrando C, Mantovani A, Allavena P.

J Immunol. 2010 Jul 1;185(1):642-52. doi: 10.4049/jimmunol.1000413. Epub 2010 Jun 7.

7.

Effects of cigarette smoking on the human urinary proteome.

Airoldi L, Magagnotti C, Iannuzzi AR, Marelli C, Bagnati R, Pastorelli R, Colombi A, Santaguida S, Chiabrando C, Schiarea S, Fanelli R.

Biochem Biophys Res Commun. 2009 Apr 10;381(3):397-402. doi: 10.1016/j.bbrc.2009.02.055. Epub 2009 Feb 15.

PMID:
19222993
8.

Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides.

Macconi D, Chiabrando C, Schiarea S, Aiello S, Cassis L, Gagliardini E, Noris M, Buelli S, Zoja C, Corna D, Mele C, Fanelli R, Remuzzi G, Benigni A.

J Am Soc Nephrol. 2009 Jan;20(1):123-30. doi: 10.1681/ASN.2007111233. Epub 2008 Dec 17.

9.

Estimating community drug abuse by wastewater analysis.

Zuccato E, Chiabrando C, Castiglioni S, Bagnati R, Fanelli R.

Environ Health Perspect. 2008 Aug;116(8):1027-32. doi: 10.1289/ehp.11022.

10.

Mass spectrometric analysis of illicit drugs in wastewater and surface water.

Castiglioni S, Zuccato E, Chiabrando C, Fanelli R, Bagnati R.

Mass Spectrom Rev. 2008 Jul-Aug;27(4):378-94. doi: 10.1002/mas.20168. Review.

PMID:
18421768
11.

Illicit drugs, a novel group of environmental contaminants.

Zuccato E, Castiglioni S, Bagnati R, Chiabrando C, Grassi P, Fanelli R.

Water Res. 2008 Feb;42(4-5):961-8. Epub 2007 Sep 21.

PMID:
17935751
12.

Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry.

Castiglioni S, Zuccato E, Crisci E, Chiabrando C, Fanelli R, Bagnati R.

Anal Chem. 2006 Dec 15;78(24):8421-9.

PMID:
17165835
13.

Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control.

Zuccato E, Castiglioni S, Fanelli R, Reitano G, Bagnati R, Chiabrando C, Pomati F, Rossetti C, Calamari D.

Environ Sci Pollut Res Int. 2006 Jan;13(1):15-21. Review.

PMID:
16417127
14.

Proteome analysis for the identification of in vivo estrogen-regulated proteins in bone.

Pastorelli R, Carpi D, Airoldi L, Chiabrando C, Bagnati R, Fanelli R, Moverare S, Ohlsson C.

Proteomics. 2005 Dec;5(18):4936-45.

PMID:
16237733
15.

Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse.

Zuccato E, Chiabrando C, Castiglioni S, Calamari D, Bagnati R, Schiarea S, Fanelli R.

Environ Health. 2005 Aug 5;4:14.

16.

Peripheral biomarkers of oxidative damage in Alzheimer's disease.

Chiabrando C, Fanelli R, Lucca U.

Ann Neurol. 2003 Mar;53(3):419-20; author reply 420. No abstract available.

PMID:
12601718
17.

Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors.

Chiabrando C, Avanzini F, Rivalta C, Colombo F, Fanelli R, Palumbo G, Roncaglioni MC; PPP Collaborative Group on the antioxidant effect of vitamin E .

Curr Control Trials Cardiovasc Med. 2002 Mar 19;3(1):5.

18.

Identification of metabolites from type III F2-isoprostane diastereoisomers by mass spectrometry.

Chiabrando C, Rivalta C, Bagnati R, Valagussa A, Durand T, Guy A, Villa P, Rossi JC, Fanelli R.

J Lipid Res. 2002 Mar;43(3):495-509.

19.

Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo.

Vulcano M, Albanesi C, Stoppacciaro A, Bagnati R, D'Amico G, Struyf S, Transidico P, Bonecchi R, Del Prete A, Allavena P, Ruco LP, Chiabrando C, Girolomoni G, Mantovani A, Sozzani S.

Eur J Immunol. 2001 Mar;31(3):812-22.

20.

Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-Prostaglandin F2alpha.

Chiabrando C, Valagussa A, Rivalta C, Durand T, Guy A, Zuccato E, Villa P, Rossi JC, Fanelli R.

J Biol Chem. 1999 Jan 15;274(3):1313-9.

21.

Spinning more yarn: endozepine.

Riva R, Lugwesi E, Fanelli R, Mennini T, Chiabrando C.

Lancet. 1998 Apr 11;351(9109):1138. No abstract available.

PMID:
9660622
22.

Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man.

Bachi A, Brambilla R, Fanelli R, Bianchi R, Zuccato E, Chiabrando C.

Br J Pharmacol. 1997 Aug;121(8):1770-4.

24.

Urinary excretion of 2,3-dinor-thromboxane B1, a major metabolite of thromboxane B2 in the rat.

Chiabrando C, Corada M, Bachi A, Fanelli R.

Prostaglandins. 1994 Jun;47(6):409-22.

PMID:
7938613
25.

Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry.

Djurup R, Chiabrando C, Jörres A, Fanelli R, Foegh M, Soerensen HU, Joergensen PN.

Clin Chem. 1993 Dec;39(12):2470-7.

26.

Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man.

Chiabrando C, Rivoltella L, Alberti E, Bonollo M, Djurup R, Fanelli R.

Prostaglandins. 1993 May;45(5):401-11.

PMID:
8321910
28.

Thromboxane B2 urinary metabolites in patients undergoing cardiopulmonary bypass.

Jörres A, Chiabrando C, Kordonouri O, Schiessler A, Hess S, Farke S, Gahl GM, Müller C, Rivoltella L, Djurup R.

Eicosanoids. 1992;5(3-4):147-51.

PMID:
1292525
29.

A study on the biological behavior of human brain tumors. Part II: Steroid receptors and arachidonic acid metabolism.

Butti G, Gaetani P, Chiabrando C, Assietti R, Zibera C, Castelli MG, Gibelli N, Silvani V, Robustelli della Cuna G, Paoletti P.

J Neurooncol. 1991 Jun;10(3):241-6.

PMID:
1910079
30.

A study on the biological behavior of human brain tumors. Part I. Arachidonic acid metabolism and DNA content.

Gaetani P, Butti G, Chiabrando C, Danova M, Castelli MG, Riccardi A, Assietti R, Paoletti P.

J Neurooncol. 1991 Jun;10(3):233-40.

PMID:
1910078
31.

Metabolism of thromboxane B2 in the isolated perfused rat kidney: mass spectrometric identification of urinary products.

Chiabrando C, Pinciroli V, Perico N, Campoleoni A, Benigni A, Remuzzi G, Fanelli R.

Biochim Biophys Acta. 1989 Nov 28;1006(2):167-72.

PMID:
2597664
33.

Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.

Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, Orisio S, Piccinelli A, Pinciroli V, Fanelli R, et al.

N Engl J Med. 1989 Aug 10;321(6):357-62.

PMID:
2664523
34.

Renal metabolism and urinary excretion of thromboxane B2 in the rat.

Benigni A, Chiabrando C, Perico N, Fanelli R, Patrono C, FitzGerald GA, Remuzzi G.

Am J Physiol. 1989 Jul;257(1 Pt 2):F77-85.

PMID:
2750927
35.

Prostaglandin and thromboxane synthesis by human intracranial tumors.

Castelli MG, Chiabrando C, Fanelli R, Martelli L, Butti G, Gaetani P, Paoletti P.

Cancer Res. 1989 Mar 15;49(6):1505-8.

36.

Antiinflammatory action of salicylates: aspirin is not a prodrug for salicylate against rat carrageenin pleurisy.

Chiabrando C, Castelli MG, Cozzi E, Fanelli R, Campoleoni A, Balotta C, Latini R, Garattini S.

Eur J Pharmacol. 1989 Jan 17;159(3):257-64.

PMID:
2920775
37.

Prostaglandins in human brain tumors.

Paoletti P, Chiabrando C, Gaetani P, Castelli MG, Butti G, Martelli L, Rolli M.

J Neurosurg Sci. 1989 Jan-Mar;33(1):65-9. Review.

PMID:
2674360
38.

Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.

Benigni A, Chiabrando C, Piccinelli A, Perico N, Gavinelli M, Furci L, Patino O, Abbate M, Bertani T, Remuzzi G.

Kidney Int. 1988 Aug;34(2):164-74.

39.

Metabolism of arachidonic acid in isolated glomeruli from pig kidney.

Livio M, Chiabrando C, Macconi D, Benigni A, Zimei M, De Pietro MT, Remuzzi G.

Biochim Biophys Acta. 1988 Jul 1;961(1):110-21.

PMID:
3132983
40.

Mass spectrometric identification of urinary and plasma metabolites of 9-hydroxy-19,20-bis-nor-prostanoic acid (rosaprostol).

Benfenati E, Fanelli R, Chiabrando C, Valcavi U, Bosone E, Farina P.

Prostaglandins. 1988 May;35(5):665-84.

PMID:
3399677
41.

Antibody-mediated extraction/negative-ion chemical ionization mass spectrometric measurement of thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine.

Chiabrando C, Benigni A, Piccinelli A, Carminati C, Cozzi E, Remuzzi G, Fanelli R.

Anal Biochem. 1987 May 15;163(1):255-62.

PMID:
3619026
42.

Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.

Chiabrando C, Broggini M, Castelli MG, Cozzi E, Castagnoli MN, Donelli MG, Garattini S, Giavazzi R, Fanelli R.

Cancer Res. 1987 Feb 15;47(4):988-91.

43.

Arachidonic acid metabolic profiles in human meningiomas and gliomas.

Castelli MG, Butti G, Chiabrando C, Cozzi E, Fanelli R, Gaetani P, Silvani V, Paoletti P.

J Neurooncol. 1987;5(4):369-75.

PMID:
3126274
44.

Prostaglandin and thromboxane synthesis by Lewis lung carcinoma during growth.

Chiabrando C, Broggini M, Castagnoli MN, Donelli MG, Noseda A, Visintainer M, Garattini S, Fanelli R.

Cancer Res. 1985 Aug;45(8):3605-8.

45.

Further studies on the mechanism of action of human plasma in stimulating prostacyclin production by rat smooth muscle cells.

Vergara-Dauden M, Balconi G, Breviario F, Chiabrando C, de Gaetano G, Dejana E.

Thromb Haemost. 1985 Jun 24;53(3):372-6.

PMID:
3931285
46.

Prostaglandins and aminoglycoside nephrotoxicity.

Assael BM, Chiabrando C, Gagliardi L, Noseda A, Bamonte F, Salmona M.

Toxicol Appl Pharmacol. 1985 May;78(3):386-94.

PMID:
4049389
47.
48.

Characterization of arachidonic acid metabolic profiles in animal tissues by high-resolution gas chromatography-mass spectrometry.

Chiabrando C, Noseda A, Novella Castagnoli M, Salmona M, Fanelli R.

Biochim Biophys Acta. 1984 Jul 6;794(2):292-7.

PMID:
6428459
49.

Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products.

Bertelé V, Falanga A, Tomasiak M, Chiabrando C, Cerletti C, de Gaetano G.

Blood. 1984 Jun;63(6):1460-6.

50.

Is immunoreactive 6-keto-PGF1 alpha measured in serum after treatment with thromboxane-synthetase inhibitors an index of prostacyclin synthesis?

Cerletti C, Chiabrando C, Fanelli R, de Gaetano G.

Lancet. 1984 Apr 28;1(8383):967-8. No abstract available.

PMID:
6143907

Supplemental Content

Loading ...
Support Center